Bristol's Abecma, Amgen's Lumakras headline record-setting oncology launch class as costs continue to balloon: IQVIA

A flurry of innovation in oncology has led to a record number of new cancer drugs launched globally in 2021. But spending on oncology medicines also reached a new high.

The world welcomed 30 novel oncology medicines in 2021, IQVIA found in its annual Global Oncology Trends report published Thursday. That’s compared to 104 new rollouts in the past five years.